TY - JOUR
T1 - Pharmacology of trimethoprim-sulfamethoxazole in newborn infants
AU - Lietman, Paul S.
AU - Springer, Chaim
AU - Eyal, Fabian
AU - Michel, Jacques
PY - 1982/4
Y1 - 1982/4
N2 - The pharmacokinetic parameters of sulfamethoxazole and trimethoprim were measured in 12 newborn infants of less than 3 days postnatal age, following a single or repeated intravenous injection. The mean half-lives for SMZ and TMP were 16.5 hours and 19.0 hours, respectively. The mean volumes of distribution were SMZ 0.48 L/kg and TMP 2.7 L/kg. The mean drug clearances were SMZ 0.65 ml/minute and TMP 3.31 ml/minute. From these data the recommended loading dose is SMZ 10 mg/kg with TMP 3 mg/kg, and the maintenance dose is SMZ 3 mg/kg with TMP 1 mg/kg twice daily. No adverse side effects were seen during treatment, and the bilirubin-binding capacity of albumin was not changed at therapeutic concentrations of the antimicrobial drugs.
AB - The pharmacokinetic parameters of sulfamethoxazole and trimethoprim were measured in 12 newborn infants of less than 3 days postnatal age, following a single or repeated intravenous injection. The mean half-lives for SMZ and TMP were 16.5 hours and 19.0 hours, respectively. The mean volumes of distribution were SMZ 0.48 L/kg and TMP 2.7 L/kg. The mean drug clearances were SMZ 0.65 ml/minute and TMP 3.31 ml/minute. From these data the recommended loading dose is SMZ 10 mg/kg with TMP 3 mg/kg, and the maintenance dose is SMZ 3 mg/kg with TMP 1 mg/kg twice daily. No adverse side effects were seen during treatment, and the bilirubin-binding capacity of albumin was not changed at therapeutic concentrations of the antimicrobial drugs.
UR - http://www.scopus.com/inward/record.url?scp=0020084057&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0020084057&partnerID=8YFLogxK
U2 - 10.1016/S0022-3476(82)80778-6
DO - 10.1016/S0022-3476(82)80778-6
M3 - Article
C2 - 7062219
AN - SCOPUS:0020084057
SN - 0022-3476
VL - 100
SP - 647
EP - 650
JO - Journal of Pediatrics
JF - Journal of Pediatrics
IS - 4
ER -